Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Receivables - Other (2022 - 2025)

Historic Receivables - Other for GE HealthCare Technologies (GEHC) over the last 4 years, with Q4 2025 value amounting to $645.0 million.

  • GE HealthCare Technologies' Receivables - Other rose 950.76% to $645.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $645.0 million, marking a year-over-year increase of 950.76%. This contributed to the annual value of $645.0 million for FY2025, which is 950.76% up from last year.
  • As of Q4 2025, GE HealthCare Technologies' Receivables - Other stood at $645.0 million, which was up 950.76% from $368.0 million recorded in Q3 2025.
  • GE HealthCare Technologies' Receivables - Other's 5-year high stood at $685.0 million during Q3 2024, with a 5-year trough of $299.0 million in Q1 2025.
  • Its 4-year average for Receivables - Other is $556.4 million, with a median of $600.0 million in 2023.
  • Its Receivables - Other has fluctuated over the past 5 years, first surged by 8375.8% in 2024, then plummeted by 4818.02% in 2025.
  • GE HealthCare Technologies' Receivables - Other (Quarter) stood at $584.0 million in 2022, then rose by 2.74% to $600.0 million in 2023, then decreased by 1.83% to $589.0 million in 2024, then increased by 9.51% to $645.0 million in 2025.
  • Its Receivables - Other was $645.0 million in Q4 2025, compared to $368.0 million in Q3 2025 and $669.0 million in Q2 2025.